Introduction
Neuroinflammation, orchestrated primarily by microglial activation, remains a core pathological driver across neurodegenerative conditions such as Alzheimer's disease. Transient receptor potential vanilloid 1 (TRPV1), a polymodal non-selective cation channel, is increasingly recognized as an important immunoregulatory receptor. While capsaicin—the primary pungent constituent of chili peppers—exhibits well-documented anti-inflammatory properties as a TRPV1 agonist, the prevailing dogma has strictly attributed TRPV1’s protective actions to its canonical Ca²⁺ ion-conduction and downstream metabolic or autophagic cascades.
A landmark study recently published in Translational Neurodegeneration by Hou et al. upends this traditional paradigm. The researchers demonstrate that capsaicin suppresses microglial inflammation not through canonical ion flux, but via a novel protein-protein interaction paradigm: enhancing the coupling between TRPV1 and signal sequence receptor subunit 4 (SSR4).
Detailed Methodology
To uncover this non-canonical mechanism, the research team deployed an integrated workflow combining in vivo neuroinflammation models, proximity-labeling proteomics, and live-cell biophysical assays:
In Vivo & In Vitro Neuroinflammation Models: An acute neuroinflammation model was established using wild-type (WT) and Trpv1-knockout (KO) mice, alongside primary mouse microglia, BV2 microglial cells, and human HMC3 microglia stimulated with lipopolysaccharide (LPS).
Pharmacological Blockade: Capsazepine was introduced to pharmacologically inhibit capsaicin-evoked TRPV1 channel gating, allowing investigators to uncouple ion flux from anti-inflammatory outcomes.
Proximity-Labeling Proteomics: To map TRPV1-associated proteins, the team engineered and optimized two proximity-labeling systems—PUP-IT (Pupylation-based Interaction Tagging) and TurboID—fusing PafA or TurboID to the N- or C-termini of TRPV1. Biotinylated proteins were isolated via streptavidin pull-down and analyzed using a Q Exactive HF hybrid quadrupole-Orbitrap mass spectrometer.
Interaction Validation Assays: Candidate interactors were validated using Bioluminescence Resonance Energy Transfer (BRET), NanoLuc Binary Technology (NanoBiT), and co-immunoprecipitation (CO-IP) assays.
Functional & Structural Characterization: Functional consequences were evaluated via siRNA-mediated knockdowns, intracellular calcium mobilization assays, fluorescent microsphere phagocytosis assays, and transcriptome sequencing (RNA-seq). Furthermore, AlphaFold3 structural modeling and BRET-based domain mapping were utilized to delineate the structural determinants of SSR4 recruitment.
Key Results
1. TRPV1-Dependent Anti-Inflammatory Effects Independent of Ion Gating
In LPS-challenged WT mice, capsaicin pre-treatment significantly attenuated pro-inflammatory cytokine production (IL-6 and TNF-α), reduced neuronal apoptosis (indicated by cleaved caspase-3 staining), curtailed microgliosis, and reversed microglial soma enlargement. Crucially, all of these neuroprotective and anti-inflammatory effects were completely abolished in Trpv1 KO mice, confirming strict TRPV1 dependence.
However, when the TRPV1 channel antagonist capsazepine was administered to block canonical channel gating and Ca²⁺ influx, it failed to reverse the anti-inflammatory actions of capsaicin both in vitro and in vivo. This core contradiction—wherein channel blockade does not disrupt the drug's therapeutic efficacy—compelled the search for a non-canonical, protein-interaction-based mechanism.
2. Identification of SSR4 via Proximity-Labeling Proteomics
Using the PUP-IT proximity-labeling screen, mass spectrometry identified eight candidate TRPV1-interacting proteins. Subsequent functional screening and NanoBiT/BRET validation isolated SSR4 (signal sequence receptor subunit 4, the TRAPδ subunit of the endoplasmic reticulum translocon complex) as a primary candidate.
BRET assays and co-immunoprecipitation demonstrated that capsaicin selectively enhanced the physical interaction between TRPV1 and SSR4, whereas it promoted no such change with other candidate pairs.
3. Functional Necessity of the TRPV1–SSR4 Axis
Loss-of-Function: Knockdown of SSR4 in microglia significantly blunted capsaicin’s ability to suppress inflammatory cytokine expression (IL-6, IL-1β) and curtailed its inhibition of pathological microglial phagocytosis.
Gain-of-Function: To test sufficiency, the investigators established a rapamycin-inducible heterodimerization system (FKBP12/FRB) to artificially force proximity between TRPV1 and SSR4. Forced TRPV1–SSR4 dimerization successfully and partially mimicked capsaicin’s anti-inflammatory effects, significantly reducing TNF-α transcription in LPS-stimulated microglia.
Structural Mapping: AlphaFold3 modeling and BRET-based domain mapping revealed that the transmembrane region of TRPV1 serves as the major structural determinant supporting SSR4 recruitment.
Commentary & Perspective
This study marks a conceptual turning point in our understanding of transient receptor potential channels, offering profound implications for neuropharmacology and drug design:
Expanding the Paradigm from Ion Conduction to Interoceptive Protein Interacting: Historically, targeting TRPV1 focused entirely on modulating ion conductance, often hampered by intolerable thermal and nociceptive side effects driven by channel pore opening. By demonstrating that capsaicin's anti-inflammatory efficacy can be decoupled from channel gating, this work establishes a novel signaling axis where TRPV1 acts as a structural scaffold rather than merely an ion gate.
Linking Endoplasmic Reticulum (ER) Homeostasis to Neuroinflammation: Positioning SSR4—an integral component of the ER translocon complex—at the center of microglial inflammatory regulation unveils a previously unappreciated bridge between ER protein handling and innate immune signaling. It suggests that receptor-ER structural coupling may coordinate the cellular protein-processing load with inflammatory output during neurodegeneration.
A New Horizon for Drug Discovery (Target Druggability): While future investigations must resolve the exact subcellular localization sites and downstream signaling intermediates of the TRPV1–SSR4 complex, the discovery of ligand-enhanced protein-protein interaction paradigms opens an exciting therapeutic window. This provides a robust chemical biology foundation to design biased, non-ionotropic TRPV1 agonists or small-molecule stabilizers that selectively trigger anti-inflammatory protein interactions while safely bypassing on-target channel-mediated side effects.
Reference
Hou Y, Wang S, Yang Y, Zhao Z, Xie Y, Ouyang X, Zhang K, Chen H, Xu J. Capsaicin suppresses microglial inflammation through TRPV1-SSR4 interaction. Transl Neurodegener. 2026 Oct 21;15(1):57. doi: 10.1186/s40035-026-00589-7. PMID: 42902421; PMCID: PMC13685340.
